mastodon.online is one of the many independent Mastodon servers you can use to participate in the fediverse.
A newer server operated by the Mastodon gGmbH non-profit

Server stats:

10K
active users

#icanhazpdf

3 posts3 participants0 posts today

Offenbar ist das die neue Tauschbörse von Alexandra Elbakyan, der Gründerin von #SciHub: sci-net.xyz/ (mir fehlt es an einem invite code um auszuprobieren)

„When someone struggles to access paywalled research article, they can post a request on Sci-Net. The other member who have access through university subscription will solve the request by uploading a PDF file.“

Erinnert an #ICanHazPDF – und das Tokensystem an die Belohnungsmechanismen aus früheren Warez Groupz

sci-net.xyzSci-Net

Neue von #SciHub. sci-net.xyz als Alternative zu social media basierten Verfahren wie #icanhazpdf. Konto anlegen (wohl nur Name/Passwort aber (noch?) mit invite). DOI suchen und wenn nicht verfügbar kann "die Community" wenn sie Zugriff hat das PDF hochladen das dann auch in SciHub landet und dauerhaft verfügbar ist. PDF wird wohl vor dem ausspielen auch von bekannten Kennzeichnungen wie watermarks oder IP-Adressen bereinigt. Und es gibt SciHub-MemeCoins für Uploader*innen. #Schattenbibliothek

Anyone got access to the PDF for doi.org/10.2174/13894501196661 ? #ICanHazPDF

(Got it, thanks everyone!)

http://www.eurekaselect.comDisrupting Acetyl-lysine Interactions: Recent Advance in the Development of BET InhibitorsBackground: Histone acetylation is an essential approach of post-translational modification (PTM) and a significant component of epigenetic regulation that is mediated by Bromodomainscontaining protein (BRDs). In recent years, many researchers have found that a variety of malignancy, inflammatory and other diseases occurrences and developments are associated with BRD4 expression disorders or dysfunction. Meanwhile, many inhibitors of the extra-terminal (BET) family have been reported in many papers. Objective: This review summarized those newly found BET inhibitors, their mechanism of action and bioactivity. Secondly, those compounds were mainly classified based on their structures and their structure-activity relationship information was discussed. Beyond that, every compound’s design strategy was pointed out. Results and Conclusion: Herein, the recent advances reported were reviewed for discovering more excellent small molecule inhibitors. Currently, in addition to compound 4, compounds 7, 22 and 90, have also been into the clinical trial stage. In the view of the outstanding performance of BET inhibitors in anti-tumor, anti-inflammatory and anti-drug resistance, we believe that more and more BET inhibitors will become the new epigenetic therapy for cancer, inflammation and autoimmune disease in clinical practice in the near future.
Replied in thread

@aeryn_thrace unfortunately, contacting authors introduces delays, and, while I've had a pretty good success rate, it's not 100%. I understand that academics can get barraged with emails and requests can slip through the cracks.

ILL also takes time, and there are instant methods of fulfilling requests like ResearchGate, sci-hub, and anna's archive.

Even #icanhazpdf and r/scholar tend to be faster than contacting authors directly.

Replied in thread

@julian_b @aeryn_thrace Sci-Hub has not updated articles since 2021 due to ongoing legal cases.

Anna's Archive is probably the easiest way to search for papers that are not in sci-hub, the Nexus Telegram bot is another way. I'm not sure what success folks have had with including a doi with the #icanhazpdf hashtag on mastodon, but it seems to be gaining some traction.

As a last resort, the r/scholar subreddit has never failed me, though I try to avoid reddit these days.